Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

Expenses by nature (Schedule of Expenses by Nature) (Details)

v3.20.1
Expenses by nature (Schedule of Expenses by Nature) (Details) - CAD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Feb. 15, 2018
Dec. 31, 2019
Dec. 31, 2018
Expenses
Salaries, wages and benefits $ 7,831 $ 5,945
Other research and development expenditures, including clinical costs 13,594 8,398
Professional and consulting fees $ 285 1,779 1,987
Travel 680 550
Office, rent and telecommunications 684 586
Insurance 800 444
Marketing, communications and investor relations 1,675 1,370
Depreciation 527 325
Stock-based compensation (non-cash) 1,138 1,182
Deferred share unit compensation (non-cash) (191) 508
Other 609 800
Accreted interest 1,239 1,385
Research and development tax credits (1,571) (1,027)
Government assistance (861) (35)
Total Expenses $ 27,933 $ 22,418